The most commonly asked questions, answered
- Home
- Conditions and treatments
- Lucentis - AntiVEGF therapy for AMD
Lucentis - AntiVEGF therapy for AMD
Lucentis - AntiVEGF therapy for AMD
Lucentis is an AntiVEGF therapy and works by targeting abnormal retinal blood vessels, reducing or stopping the bleeding and leakage that can occur. This typically results in prevention of further loss of vision, and can also lead to improve vision. It is licensed to treat Wet AMD, Diabetic Macular Oedema, Central and Branch Retinal Vein Occlusion and Myopic CNV Degeneration. It is performed by a single injection into the eye, in a surgical clean room under a local anaesthetic.
Latest news
.jpg?itok=ZGMC_zfw)
Service for amputees launched
The London Clinic launches osseointegration

New partnership
The London Clinic and Schoen Clinic London form partnership

A common problem
30,000 people are diagnosed with ankle arthritis annually

node loaded statrted -->1656623161
node loaded ended -->1656623161
service_details_by_node_id statrted -->1656623161
service_details_by_node_id ended -->1656623161
taxanomy_tagged_with_page statrted -->1656623161
taxanomy_tagged_with_page ended -->1656623161
gold_people_list_by_product_ids statrted -->1656623161
gold_people_list_by_product_ids ended -->1656623161
get_pople_details_by_id started -->1656623161
get_pople_details_by_id ended -->1656623161
function ended -->1656623161